Determination of methylphenidate in plasma and saliva by liquid chromatography/tandem mass spectrometry
Highlights
► A LC–MS/MS method was validated for the determination of methylphenidate (MPH) in plasma and saliva. ► The method allows fast, accurate and precise quantification of MPH in both plasma and saliva. ► The use of deuterated MPH as an internal standard is essential, due to matrix effects of plasma. ► MPH is degraded in plasma and saliva; clinical samples should be stored at −20 °C directly after sampling.
Introduction
Methylphenidate (MPH) is a psychostimulant widely used in the treatment of attention-deficit hyperactivity disorder (ADHD). ADHD is a neurobehavioral problem mostly encountered in school-aged children at a prevalence of 5–10% of the general population [1], [2]. MPH is a piperidine-derived molecule that contains two chiral centers and exists as four stereoisomers (Fig. 1). The pharmacological activity resides entirely with the dl-threo-methylphenidate racemic (50:50) mixture [3].
The major metabolic pathway of MPH is the hydrolysis of the methyl ester linkage by esterases to form ritalinic acid [4], [5]. Minor metabolic pathways for both these compounds include parahydroxylation of the aromatic ring, oxidation to 6-oxo-dervatives and glucuronide formation [6], [7]. Ritalinic acid and the other metabolites are pharmacologically inactive [8], [9], [10].
There is a clinical need to perform therapeutic drug monitoring (TDM) in patients who are undergoing MPH therapy. MPH exhibits wide inter-individual variability in both pharmacokinetics and clinical response [11], [12]. TDM can be applied when the patient remains unresponsive to therapy, exhibits unexpected adverse events or to check adherence. In adults, clinical monitoring of MPH therapy is usually performed by measuring plasma MPH concentrations. In children, monitoring of drug levels should be performed with minimal discomfort for the patient. Monitoring of MPH concentrations in saliva may therefore be an interesting non-invasive alternative to blood sampling as demonstrated earlier by Marchei and coworkers [13].
Several methods have been developed for quantification of MPH in plasma, urine and hair, using high-performance liquid chromatography (HPLC) with ultraviolet detection [6], [14], capillary electrophoresis-mass spectrometry [15], gas chromatography–mass spectrometry [8], [9], [16] and liquid chromatography–tandem mass spectrometry [7], [13], [17], [18]. The determination of MPH concentrations by standard reversed-phase (RP) chromatography coupled to MS/MS detection is particularly challenging since retention times may be short due to the high hydrophilicity of the compound. This may produce a significant loss in sensitivity due to the co-elution with matrix interference and the high percentage of water at the chromatographic elution time. Recent research however has shown that for hydrophilic compounds the sensitivity, precision and accuracy of a quantitative analytical chromatographic method may be improved by using hydrophilic interaction liquid chromatography (HILIC) [19]. In addition, the use of HILIC has advantages in sample preparation when measuring polar compounds. Because of the high organic modifier content, usually acetonitrile, used during chromatography, proteins can be precipitated using organic solvents without the loss of chromatographic integrity, as is often the case when used with polar compounds in combination with RP chromatography. A high organic modifier concentration is also ideal for compound ionization by electrospray ionization mass spectrometry (ESI-MS), resulting in higher sensitivity.
The aim of the present study was to develop a method to determine MPH concentrations in human plasma and saliva for potential use in therapeutic drug monitoring. We present the development and validation of an analytical method using HILIC chromatography coupled to tandem mass spectrometry. The stability of MPH in plasma and saliva was investigated at different temperatures. The applicability of the method was demonstrated with plasma and saliva data from one healthy adult volunteer obtained before and after intake of 10 mg immediate release (IR) MPH and 18 mg MPH – osmotic controlled-release oral delivery system (OROS) – on different occasions.
Section snippets
Chemicals
Methylphenidate was purchased from Bufa (Uitgeest, Netherlands). As an internal standard (I.S.) a 1 mg/mL solution of deuterated methylphenidate HCl (d9-MPH) in methanol was obtained from LGC-Standards (Teddington, United Kingdom) (Fig. 1). Water was purified and deionized using an ELGA purelab Optron Q (Veolia Water; Saint Maurice, France). Drug free, non sterile, K2 EDTA human plasma was obtained from Equitech-Bio (Kerrville – TX, USA). OraFlx synthetic saliva was obtained from Dyna-Tek
Chromatography
Using electrospray in the positive mode MS parameters were tuned to produce maximum responses for MPH and the internal standard d9-MPH. The protonated molecular ions [M+H]+ were m/z 234.1 and 243.1, respectively. The MS2 spectra of both methylphenidate and d9-methylphenidate are given in Fig. 2; the most abundant product ions were m/z 84.1 and 93.1, respectively.
The chromatographic results after injection of drug free plasma and saliva, a LLOQ sample and a patient receiving MPH are shown in
Conclusion
An LC–MS/MS method using hydrophilic interaction liquid chromatography has been successfully developed for determination of MPH concentrations in plasma and saliva. The method has proven to be rapid, sensitive, accurate and precise. Due to matrix effects of plasma, the use of deuterated MPH as an internal standard was essential. Stability experiments demonstrated that samples should be stored at temperatures of −20 °C or below directly after sampling, and that samples should be processed
Acknowledgements
The authors wish to thank the staff of the department of Hospital Pharmacy – Clinical Pharmacology Unit of Academic Medical Center Amsterdam for skillful assistance and gratefully acknowledge the fruitful cooperation with the Center for Human Drug Research.
References (29)
J. Am. Acad. Child Adolesc. Psychiatry
(1996)- et al.
Lancet
(1998) - et al.
J. Pharm. Sci.
(1992) - et al.
Clin. Biochem.
(2004) - et al.
J. Chromatogr. B: Biomed. Sci. Appl.
(1998) - et al.
Forensic Sci. Int.
(2010) - et al.
J. Pharm. Biomed. Anal.
(2009) Anal. Chim. Acta
(2011)Clin. Biochem.
(2005)- et al.
J. Pharm. Biomed. Anal.
(2011)
J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci.
J. Pharm. Biomed. Anal.
CNS Drugs
Clin. Pharmacol. Ther.
Cited by (23)
Detection and quantification of methylphenidate and ritalinic acid in keratinized matrices
2023, Toxicologie Analytique et CliniqueDevelopment of analytical method for the determination of methylphenidate, the analog ethylphenidate and their metabolite ritalinic acid in oral fluid samples by micro-QuEChERS and liquid chromatography–tandem mass spectrometry
2022, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life SciencesChiral separation and quantification of d,l-methylphenidate, d,l-ethylphenidate and ritalinic acid in blood by LC-MS/MS
2022, Forensic ChemistryCitation Excerpt :There has been extensive research analyzing MPH and its metabolite, RA, using liquid chromatography-mass spectrometry (LC-MS/MS) in blood [23], plasma [23–28], urine [18,29,30], oral fluid [8,23,25,27,31], breath [29], and dried blood spots [32]. MPH and RA were isolated from these matrices through a variety of extraction techniques such as liquid–liquid extraction (LLE) [26], protein precipitation [23,25,28,32], or a simple dilution [8,18,24,30]. However, these methods were not enantioselective and did not separate the enantiomers of these analytes.
Development and validation of an HPLC-UV method for analysis of methylphenidate hydrochloride and loxapine succinate in an activated carbon disposal system
2018, Journal of Pharmaceutical AnalysisCitation Excerpt :The analytical accuracy of the method developed for both drugs was also tested. In the literature, there are few analytical methods reported for the determination of MPH [7,8] and loxapine succinate [9]. All the available methods are time consuming and expensive and use liquid chromatography--mass spectrometry (LC--MS) or high-performance liquid chromatography (HPLC) with multiple solvents as mobile phases.
Solid phase microextraction combined with thermal-desorption electrospray ionization mass spectrometry for high-throughput pharmacokinetics assays
2018, Analytica Chimica ActaCitation Excerpt :Determination of methylphenidate in biological fluids is therefore not only important for pharmacokinetics purposes but for diagnosing substance abuse or doping. Quantification of methylphenidate in biological fluid is usually performed using traditional LC-MS/MS approaches [35, 36] and by which is inevitably increase time and labor costs. To simplify and expedite the analysis of methylphenidate in blood, SPME fibers coated with relatively nonpolar polydimethylsiloxane (PDMS) were used for head space extraction followed by GC-MS detection [37, 38].